about
RIFINs are adhesins implicated in severe Plasmodium falciparum malariaPlasmodium falciparum antigen 332 is a resident peripheral membrane protein of Maurer's cleftsBinding of subdomains 1/2 of PfEMP1-DBL1α to heparan sulfate or heparin mediates Plasmodium falciparum rosetting.Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1α.A sequence in subdomain 2 of DBL1α of Plasmodium falciparum erythrocyte membrane protein 1 induces strain transcending antibodies.B-cell epitopes in NTS-DBL1α of PfEMP1 recognized by human antibodies in Rosetting Plasmodium falciparumA Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites.Elevated levels of high-mobility group box-1 (HMGB1) in patients with severe or uncomplicated Plasmodium falciparum malaria.The aryl hydrocarbon receptor controls cell-fate decisions in B cells.Defining B cell immunodominance to virusesPhagocytosis-inducing antibodies to Plasmodium falciparum upon immunization with a recombinant PfEMP1 NTS-DBL1α domainWild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance.Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center StageInfluenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stemNeuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodiesOutflanking immunodominance to target subdominant broadly neutralizing epitopes
P50
Q27972159-2BA1909B-A49F-43B7-A6A0-7A686CE28580Q28485271-15FC90CA-0F0F-4726-9382-CF816E304080Q34465843-C9A840D5-1F9E-4C4F-BC2F-BF8A04C50499Q34507076-083E0A01-1D4E-445F-824B-D3EF7B2CFAABQ34555650-E82A259B-D45B-46BF-8B55-A183DC1846F0Q34599635-F44BBF90-46CD-46C7-9EEC-D19845E29FF1Q35921799-B3BBB814-BE0B-40CC-9C48-E2AA91C1FAA7Q36689554-FDA9A3FC-D2BC-408C-B401-E3B1F0297210Q36743870-82A1091C-9890-4274-8203-B06DDEF6A541Q37549732-22AF2F42-5051-4681-BDED-7B4EA086A2C6Q40335009-B41C9494-E925-4676-9EEA-09392B8A1E35Q40573273-F179EAA5-4D1D-4304-8087-92D854344011Q46278248-5754A9BE-A25B-4D74-81B5-A4A7E189B89FQ47550457-F7C1D65D-F298-4FD6-B68C-71011287B477Q59360699-2B83EB2C-E743-44F5-A67A-A4CBC6BD0FF7Q89802109-9EC1E1F9-913C-4C89-BBF2-C25A73FBC8CCQ91228791-C8B288FB-C422-40AB-8B81-275D7714930BQ92859858-C9E6A58D-2578-4687-BE40-0BB2EB423ECA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Davide Angeletti
@ast
Davide Angeletti
@en
Davide Angeletti
@es
Davide Angeletti
@nl
Davide Angeletti
@sl
type
label
Davide Angeletti
@ast
Davide Angeletti
@en
Davide Angeletti
@es
Davide Angeletti
@nl
Davide Angeletti
@sl
prefLabel
Davide Angeletti
@ast
Davide Angeletti
@en
Davide Angeletti
@es
Davide Angeletti
@nl
Davide Angeletti
@sl
P106
P1153
55496477200
P31
P496
0000-0002-5256-1972